Hematological Malignancies Clinical Trial
Official title:
An Evaluation of the Effect of 'Open Window', an Art Intervention, on Psychological Well-being and Experience of Stem Cell Transplantation for the Treatment of Haematological Malignancies
The 'Open Window' Study is a prospective longitudinal study using a 4 group randomised
control trial design to evaluate the psychological effect of 'Open Window' on the
consequences of long term isolation on patients undergoing stem cell transplantation
treatment of haematological malignancies. This study uses a randomised control trial design,
which is widely used in healthcare settings to test the effects of interventions and testing
cause and effect relationships between variables. A mixed methods approach for data
collection and data analysis is being used. This will facilitate measurement of patients'
psychological response to 'Open Window' using questionnaires and exploration of subjective
feelings in relation to personal experiences of having a stem cell transplant through semi
structured interviews.
Hypothesis to be tested
'Open Window' has no effect on patients' levels of anxiety, depression, or distress when
undergoing a stem cell transplant.
Results:
Of the 199 patients in the study, 96 were randomized to the intervention group and 103 to
the control group. Participants in the intervention group had significantly reduced levels
of anxiety on the day before transplant (P = 0.001), at day 7 (P = 0.041), and day 60 (P =
0.035). There was a significant reduction in depression before transplant (P= 0.022).
Participants in the intervention group reported better experiences (P < 0.005).
'Open Window' is a unique and novel intervention for patients being treated for
haematological malignancies in the 'National Stem Cell Transplant Unit', St. James'
Hospital, Dublin, Ireland. Treatment programmes include allogeneic and autologous stem cell
transplantation for leukaemia and related disorders. This unit comprises 21 single
air-conditioned rooms in which patients are treated and cared for. The unit is located on
the ground floor of a large hospital and the view out of most of the windows is limited to
the light railway system at best and the air conditioning unit at worst. Windows in the
rooms are quite large although light and sunlight is limited in some by an adjacent
building. The rooms vary in size and shape and all are en suite and contain a bed, locker,
easy chair and TV/video mounted high on the wall, usually to the left, in front of the
patient. All rooms are painted in magnolia with a blue door to the en suite and exit. In
order to reduce the risk of infection, flowers and pictures hanging on the walls are
prohibited and personal items such as photos are limited. Blinds are used on the windows and
bed covers are blue, pink or green. The overall effect is minimalist and clinical due to the
presence of medical equipment. Visiting is limited and children under 14 years of age are
not allowed to visit.
Although a new unit, The National Transplant Unit was not purpose built and the focus of the
design was in providing a protective environment for as many patients as possible within a
limited space and with very specific requirements. While it is arguable that the
introduction of colour to the walls and the inclusion of patterned curtains or bedspreads
might enhance the environment from a design perspective, in the absence of such an
initiative, this atmosphere provides an ideal opportunity to assess the effect of art on the
experience of a very specific group of patients in a controlled atmosphere. Redshaw (2004)
suggests that design alone does not provide spaces that are attractive, imaginative and
engaging but that it is the inclusion of art that does this. Her study on the impact of the
provision of art in a children's hospital is reported as providing a distraction for
children and parents, providing enjoyment and comfort, facilitating self-expression and
building self-esteem and confidence. This function of art in healthcare fulfills its role in
providing a healing environment and is the primary reason why it was considered an
appropriate intervention for the specific population of patients included in the 'Open
Window' project.
People have a basic need for contact with each other. Isolation from people, or separation
from familiar places, can cause feelings of despair, anger and hopelessness (Denton 1986;
Jenner 1990; Gammon 1998). Views of nature or people through a window reduce the negative
effects of isolation and can impact positively on psychological well-being (Kennedy &
Hamilton 1997, Ulrich 1983). Due to the location, design and décor of the rooms, the
patients in 'The National Stem Cell Transplant Unit' at St. James's have very little
stimulation other than TV, radio and reading. It is arguable that a patient-centred hospital
environmental design may be sufficient to make their experience more comfortable and
aesthetically pleasing; however, it is the inclusion of art in the environment that may
provide a more positive and enduring distraction for patients and have a positive influence
on a patient's sense of 'self' and well-being and overall psychological adjustment to having
a life threatening illness. This is important in providing holistic care for patients and
may influence their immediate and long-term recovery.
'Open Window' is an entirely art based intervention comprising a multimedia system that uses
a combination of video projectors, audio speakers and bespoke software to make images appear
as a 'virtual window' on the wall of the patients' room. Artists use mobile phone cameras
and camcorders to record the images that are sent to the unit over the internet and via
mobile phone networks. Original music composed for the project may also accompany the images
as they appear. The curator and artist in residence on the project can discuss with the
patient and family, the possibility of obtaining familiar and/or family images if they wish.
Patients can turn the system on, off and change the images by pressing the appropriate
button on the remote control. They can also choose to include or exclude certain images if
they wish. The volume of the music that accompanies some of the video channels can be
controlled using the remote control.
Artists are commissioned to create work for the 'Open Window' project and are aware of the
nature of the viewer and the context in which the art will be shown. The art in 'Open
Window' encourages the viewer to think about and engage in what they see from their own
personal frame of reference. The artist and theorist, Duchamp (1957, 3) described this
process as the viewer "bringing the work in contact with the external world by deciphering
and interpreting its inner qualification". These principles give patients who wish to use
'Open Window' the opportunity to become part of the creative process regardless of their
past experience or knowledge of art. Patients may benefit because 'Open Window' becomes
whatever they want it to be and helps them deal with their physical, psychological and
social needs in a unique and individualized way.
The 'Open Window' Intervention has three aims. The first is to help patients deal with being
in a restricted protective environment for 4-6 weeks. The second is to give patients a sense
of connection with the outside world and the third is to provide a medium through which
patients may reflect on having a life threatening illness, which may have immediate, and
long-term effects on their psychological adjustment to recovering from and possibly
surviving stem cell transplantation.
Results:
One hundred and ninty nine patients took part in the study, 96 were randomized to the
intervention group and 103 to the control group. The intervention group had significantly
reduced levels of anxiety on the day before transplant (P = 0.001), at day 7 (P = 0.041),
and day 60 (P = 0.035). Participants in the intervention group reported better experiences
(P < 0.005). Qualitative data showed that those in the intervention group reported that
'Open Window' was a great distraction from their illness and isolation and provided a
connection with outside 'normal' life.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03248479 -
Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies
|
Phase 1 | |
Recruiting |
NCT05454241 -
CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies
|
Phase 2 | |
Recruiting |
NCT06041815 -
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
|
||
Active, not recruiting |
NCT05005442 -
A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)
|
Phase 2 | |
Recruiting |
NCT02300571 -
Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant
|
N/A | |
Active, not recruiting |
NCT01428973 -
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
|
Phase 2 | |
Terminated |
NCT00506948 -
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
|
Phase 2 | |
Completed |
NCT00379587 -
Rituximab for Prevention of Chronic GVHD
|
Phase 1/Phase 2 | |
Completed |
NCT01162096 -
Reduced Intensity Haploidentical Transplant for Hematological Malignancies
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04557098 -
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
|
Phase 2 | |
Recruiting |
NCT04283097 -
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
|
Phase 1 | |
Completed |
NCT03067155 -
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.
|
Phase 2 | |
Completed |
NCT01725555 -
A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
Completed |
NCT00438178 -
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies
|
Phase 1 | |
Completed |
NCT03711604 -
Compassionate Use Study of Tenalisib (RP6530)
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01168882 -
Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies
|
Phase 1 | |
Completed |
NCT01246206 -
Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT
|
Phase 2 | |
Completed |
NCT01172132 -
The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"
|
N/A | |
Completed |
NCT00506402 -
A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
|
Phase 1 | |
Active, not recruiting |
NCT00163644 -
RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT
|
N/A |